Vaccines for the developing world: current status and future directions

被引:21
作者
Wenger, J [1 ]
机构
[1] WHO, Expanded Programme Immunizat Vaccines & Biol, CH-1211 Geneva 27, Switzerland
关键词
D O I
10.1016/S0264-410X(00)00356-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Developing country infectious disease problems differ substantially from those in the industrialized world, and a major effort must be made to devote necessary resources to development of vaccines for the bulk of human infectious disease suffering. At the same time, the political will must be mobilized, at international and national levels, to obtain the financial support and backing to provide these vaccines for children. Finally, efforts must be made to take advantage of new technologies now being developed which address many of the logistic and programmatic challenges faced by developing country immunization programme delivery systems.
引用
收藏
页码:1588 / 1591
页数:4
相关论文
共 12 条
[1]  
*AD HOC COMM HLTH, 1996, GLOB FOR HLTH RES RE
[2]  
[Anonymous], 1998, WKLY EPIDEMIOL REC, V73, P64
[3]  
[Anonymous], 1999, REM OBST HLTH DEV
[4]   A FRAMEWORK FOR THE EVALUATION OF VACCINES FOR USE IN THE EXPANDED PROGRAM ON IMMUNIZATION [J].
AYLWARD, B ;
KANE, M ;
BATSON, A ;
SCOTT, RM .
VACCINE, 1994, 12 (13) :1155-1159
[5]  
BERMAN S, 1985, REV INFECT DIS, V7, P674
[6]  
*GLOB ALL VACC IMM, 2000, 2 BOARD M DAV SWITZ
[7]  
*GLOB ALL VACC IMM, 1999, 1 BOARD M UN HOUS NE
[8]   Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate for prevention of pneumonia and meningitis in Gambian infants [J].
Mulholland, K ;
Hilton, S ;
Adegbola, R ;
Usen, S ;
Oparaugo, A ;
Omosigho, C ;
Weber, M ;
Palmer, A ;
Schneider, G ;
Jobe, K ;
Lahai, G ;
Jaffar, S ;
Secka, O ;
Lin, K ;
Ethevenaux, C ;
Greenwood, B .
LANCET, 1997, 349 (9060) :1191-1197
[9]  
*PAN AM HLTH ORG, 1999, EPI NEWSLETTER, V21, P1
[10]  
*PAN AM HLTH ORG, 2000, EPI NEWSLETTER, V22, P8